Pharma-Health-Insurance Integration Emerges as the New Growth Engine in China's Healthcare Industry: How to Capture the Trend?

With the advent of an aging society, and continuous changes in living environments, lifestyles, and disease spectra, various health issues have begun to emerge. Against this backdrop, people are placing increasing emphasis on their own health:This has brought unprecedented development opportunities to the medical and healthcare industry, further expanding the growth potential of the medical and healthcare services sector.

According to a report by PwC, China’s healthcare market has reached RMB 13 trillion, having experienced rapid growth over the past eight years with a compound annual growth rate (CAGR) of 13%, and has now become the second-largest market globally.

In addition to the growth in user demand,On the policy front, the state has also frequently issued documents to support the development of the medical and health industry.For example, the “Healthy China 2030” Plan issued by the State Council proposes to focus on the entire population and the full life cycle, provide equitable, accessible, systematic, and continuous health services, and achieve a higher level of health for all.

Amid this surge, the industry has given rise to hot sectors such as internet healthcare, digital therapeutics, and digital health management. Among them,The integration of pharmaceuticals, healthcare services, and insurance is also becoming a significant trend in the health industry, with leading players already emerging.Where do the opportunities lie in this field? What challenges remain to be addressed? How are leading companies strategizing their layouts? What is the future direction of evolution? Next, VCBeat will provide a comprehensive analysis.

The healthcare industry is undergoing structural changes.

Thanks to the development of digital technology in recent years,China's healthcare industry has achieved numerous breakthroughs and is now at an inflection point preceding explosive growth., for instance, the integration of healthcare services, pharmaceuticals, and insurance is accelerating, driving dual-sided transformations in both supply and demand across medical services, pharmaceutical retail, and payment models.

However,Behind the breakthroughs, the industry still faces many pain points that need to be addressed.First, the contradiction between the public’s escalating health needs and the financial burden of high medical costs; second, the urgent need to improve per-capita coverage given the limited pool of government medical insurance funds; third, pharmaceutical companies’ desire to increase patient reach while worrying about excessively low drug prices; and fourth, the insurance industry’s need to boost enrollment rates and build reputation, currently hindered by insufficient innovation drive.

It is precisely the widespread demand that has attracted numerous innovative enterprises to enter the market., and leverage their core competencies to deepen their competitive moat. For instance, some innovative enterprises focus on the consumer side by building patient communities; others empower government agencies by deepening their engagement in healthcare insurance informatization; some directly serve pharmaceutical companies to drive the digital transformation of pharmaceutical marketing; while others empower insurance enterprises by linking more medical resources and strengthening risk control capabilities.

Amid this wave, Medbanks Health has carved out a niche by pioneering innovative payment solutions. By deeply aggregating the needs of self-paying patients and integrating healthcare with insurance services, it enables patients to access cutting-edge drugs and medical services at lower costs and with greater convenience. The company has already achieved notable success and attracted significant investor interest, securing RMB 1 billion in Series B financing and over RMB 2 billion in Series C financing this year alone.

Nevertheless,Moxin Health remains committed to continuous iteration and upgrades, deepening its focus from innovative payment solutions to comprehensive healthcare services.At the “MediTrust Health 4th Anniversary and Kangfu Brand Strategy Launch Event” held on November 10, MediTrust Health announced a comprehensive brand upgrade aimed at better empowering the entire healthcare industry chain.

At the event, Li Yongzhong, General Manager of Shanghai Pharmaceuticals Holding Co., Ltd., stated that due to factors such as the rapid growth of medical expenses and the accelerating aging of China’s population, the country’s basic medical insurance fund is facing increasing payment pressures. Therefore, to build a more comprehensive, multi-tiered healthcare security system, commercial health insurance can play a greater role in participating in social governance.

“Against this backdrop and amid these market opportunities, MedXin Health has, over four years of development, emerged as a leader in the field of innovative healthcare payment solutions, launching a variety of payment options to help Chinese patients address affordability challenges,” said Li Yongzhong. “We hope that more pharmaceutical companies and insurance partners will join us in the future to collectively innovate healthcare payment models, alleviate the disease burden for more Chinese patients, and support the development of China’s multi-tiered healthcare security system.”

Over the past few years since its establishment, Magnesium Health has grown into a leading innovative healthcare services company in China. This latest upgrade signifies that Magnesium Health is undergoing another transformation, steadily advancing toward becoming a comprehensive healthcare service platform and continuously refining the closed-loop integration of pharmaceuticals, healthcare, and insurance, thereby delivering greater incremental value to the industry.

How Will MedTrust Health Navigate the Deepening Integration from Innovative Payment to Healthcare Services?

At its core, the focus must return to addressing the needs of various industry stakeholders as previously outlined: enabling users to reduce out-of-pocket expenses and access better medical service resources; helping pharmaceutical companies and healthcare institutions improve patient reach and coverage; and empowering insurers to develop insurance products, provide health management service resources, and increase enrollment rates. By satisfying these diverse needs and delivering mutual benefits, this approach will facilitate the development of a multi-tiered medical security system.

That is to say,Mgxin Health is committed to comprehensively empowering the entire healthcare industry chain and continuously helping Chinese patients and their families reduce the burden of disease.

Of course, strategic direction must ultimately be translated into concrete business layouts.To this end, the MedXin Health brand has undergone a comprehensive upgrade, with the establishment of three new sub-brands—Kangfu Health, Kangfu Smart Insurance, and Kangfu Insights—to fully empower the entire healthcare industry chain.

In greater detail,Kangfu Health primarily aggregates multi-party medical service resources to deliver a more comprehensive and higher-quality healthcare experience for users.First, as a leading patient-centric benefits and healthcare service platform, “Yao Kang Fu” has processed total payments exceeding RMB 10 billion, cumulatively saving RMB 1.2 billion in medical expenditures, and served over one million patients, including those with oncology and special diseases, chronic conditions, rare diseases, as well as insurance claims customers.It is evident that Magi Health has achieved a vertical upgrade in its user base by extending coverage from individuals with pre-existing conditions to substandard risks and healthy individuals, while also safeguarding patient health across a broader spectrum of diseases, ranging from specialized oncology drugs to chronic diseases, rare diseases, and various other medical conditions.

Additionally, the service pathway encompasses the entire process, including follow-up visits/prescription renewals, medication purchases, and disease management.

Notably, MedXin Health has extended its aggregation of medical resources into niche sectors such as medical devices. At the recent China International Import Expo (CIIE), MedXin Health partnered with Smith & Nephew to explore innovative payment models for medical devices. Specifically, they are providing various innovative payment solutions for the newly launched PICO7 single-use negative pressure wound therapy system and wound dressings. Furthermore, through the Yaokangfu platform, they offer a suite of patient benefits and services to individuals using Smith & Nephew products for standardized treatment. These include exclusive benefits, disease education, information queries on pharmacies and healthcare institutions, and reminders or appointment services for patient education activities.

From this perspective, Magnesium Health has taken a significant step forward in providing higher-quality and more comprehensive healthcare resource services, expanding its focus from specialty drug coverage to broader areas such as medical devices.

Kangfu Doctor primarily focuses on building an open and shared medical resource platform. By aggregating top-tier experts, it provides users with services such as health consultations, online follow-up visits, report interpretation, prescription renewal and medication purchase, access to special drugs in Boao Lecheng International Medical Tourism Pilot Zone, and medication guidance. Meanwhile, Kangfu Network establishes a dual network of “pharmacies + hospitals” to deliver high-quality medical services to users.

It is evident that the “Yaokangfu” platform aggregates patient demands and enhances the service experience across the entire process, while “Kangfu Doctor” and “Kangfu Network” consolidate high-quality medical service resources, thereby making the overall healthcare delivery pathway clearer and more comprehensive.

Revisiting Kangfu Zhibao, primarily empowering insurance companies in product development and providing resources such as health management services, thereby facilitating the effective implementation of relevant insurance products and increasing enrollment rates.

Specifically, “Kangfu Huiminbao” is jointly promoted with insurance companies as a government-guided inclusive insurance initiative. It is important to note the industry context: as an inclusive supplementary medical insurance program that effectively complements basic medical insurance, Huiminbao constitutes a significant component of the social security system. Its inclusiveness is primarily reflected through low enrollment thresholds, affordable premiums, and broad coverage criteria, thereby imposing stringent requirements on product design.

Leveraging its robust innovation capabilities, Meditrust Health has deeply participated in city-specific inclusive insurance programs such as “Su Hui Bao,” “West Lake Yi Lian Bao,” “Hui Qu Bao,” “Hu Hui Bao,” and “Beijing Puhui Health Insurance,” covering more than 40 cities including Beijing, Shanghai, Hangzhou, and Ningbo.

“Kangfu·Health Insurance” is an intelligent insurance tool library and technical support platform built by Medbanks Health for insurance companies, based on real-world medical scenarios. It covers the entire insurance value chain—including actuarial science, marketing, underwriting, claims processing, and cost control—driving innovation in health insurance products, enhancing the end-to-end service experience, and improving policy renewal rates.

Finally, let's look at Kangfu Insights.Positioned as a big data-driven, intelligent, and precise innovative payment solution, MedxHealth leverages its technological infrastructure to match the needs of various stakeholders in healthcare services. By employing artificial intelligence and other advanced analytics, it deeply empowers insurance companies, pharmaceutical enterprises, and patients.

In summary, Mgxin Health has established clear strategic objectives and practical implementation plans for its in-depth development in healthcare services., leveraging its four years of accumulated expertise in innovative payment and healthcare services, it will deliver greater value to users, foster robust integration among commercial insurance, healthcare, and pharmaceutical industries, tangibly enhance public benefit, and support the development of China’s multi-tiered medical security system.

Innovation is the inexhaustible driving force behind industrial development.

Currently, the healthcare industry has reached another critical juncture, with mounting challenges for market entrants. How to deliver greater and more diverse value-added benefits to users, and how to provide superior solutions in support of a multi-tiered medical security system, are testing every innovative enterprise. As an industry leader, Medbank Health is undergoing further evolution by deepening its focus from innovative payment models to comprehensive healthcare services, serving as a testament to its continuous breakthroughs and innovation.

However, it is important to note that deepening engagement in healthcare services is not an overnight endeavor, but rather a long-term strategic commitment.From the perspective of current industry development and evolution, companies entering the market not only need strong resource-linking capabilities and technical expertise, but also a deeper understanding and insight into the healthcare industry.

We believe that, with the joint efforts of innovative enterprises represented by Magi Health, the healthcare industry will unlock greater possibilities.